10times
Unverified

Biosimilars and Follow-On Biologics Americas


Speakers (Feb 2015)
Speaker
Andrea Laslop

Andrea Laslop

Head of Scientific Office, AGES PharmMed at Austrian Agency for Health and Food Safety Botswana
Speaker
Brenda Huneycutt

Brenda Huneycutt

Director at Avalere Health Washington DC, USA
Speaker
Bruce A. Leicher

Bruce A. Leicher

Senior Vice President and General Counsel at Momenta Pharmaceuticals, Inc. Boston, USA
Speaker
Elizabeth Fuller

Elizabeth Fuller

Senior Consultant (former Equity Partner), Bird & Bird LLP at Bird & Bird LLP USA
Speaker
Hillel Cohen

Hillel Cohen

Expert in Regulatory Policy, Regulatory Affairs & Scientific Strategy at Sandoz Biopharmaceuticals (a Novartis company) USA
Speaker
Jim Roach

Jim Roach

SVP, Development and CMO at Momenta Pharmaceuticals USA
Speaker
Kenneth Surowitz

Kenneth Surowitz

Vice President, Regulatory Affairs (Biologics) at Dr. Reddy's Laboratories USA
Speaker
Kevin Nelson

Kevin Nelson

Partner at Duane Morris LLP USA
Speaker
Partha Roy

Partha Roy

Principal Consultant at Parexel Baltimore, USA
Speaker
Rakesh Dixit

Rakesh Dixit

Vice President, R & D at MedImmune (AstraZeneca Biologics) Gaithersburg, USA
Speaker
Richard Di Ciccio

Richard Di Ciccio

Benefits Manager at Connecticut Children's Medical Center Hartford, USA
Speaker
Sang Hoon Lee

Sang Hoon Lee

Senior Vice President at Hanwha Biologics South Korea
Speaker
Thomas Felix

Thomas Felix

Director, R&D Policy (Global Regulatory Affairs and Safety) at Amgen USA
Speaker
Yariv Hefez

Yariv Hefez

VP Strategic Development, Business Development, Portfolio Management and Partnering (Biosimlars) at Merck Group Switzerland